Skip to Main Content

Member Notice: June Preferred Drug List Updates

Date: 06/01/20

Sunrise, Florida

Starting on June 1, 2020, there will be changes to the Preferred Drug List (PDL). Drugs on this list may need a prior authorization, which means you need approval from Sunshine Health before you fill your drug. Some drugs may need step therapy, which means you must try one drug first before you can try another drug. Other drugs are not on the list because they are not a preferred option.

Name of drug(s)

  • CALCITRIOL OINTMENT (TOPICAL)
  • CLINDAMYCIN / BENZOYL PEROXIDE (BENZACLIN) W/PUMP (TOPICAL)
  • CLOBETASOL PROPIONATE GEL (TOPICAL)
  • CORVITA (ORAL)
  • EMGALITY SYRINGE 100 MG (SUBCUTANEOUS)
  • FOSINOPRIL HCTZ (ORAL)
  • GUAIFENESIN 400 MG TABLET OTC (ORAL)
  • GUAIFENESIN LIQUID OTC (ORAL)
  • HALOBETASOL PROPIONATE OINTMENT (TOPICAL)
  • IMIQUIMOD (ZYCLARA) (TOPICAL)
  • MEGESTROL SUSPENSION (MEGACE ES) (ORAL)
  • NEBUPENT (INHALATION)
  • NEULASTA KIT (INJECTION)
  • NEULASTA SYRINGE (INJECTION)
  • PROPANTHELINE BROMIDE (ORAL)
  • SEVELAMER HCL TABLET (AG) (ORAL)
  • SEVELAMER HCL TABLET (ORAL)
  • STROVITE ONE (ORAL)

Explanation of changes

Removed from PDL – Prior authorization needed

If you are affected by these changes, please talk to your doctor. This should not conflict with your doctor’s advice. Only your doctor can decide which drugs are right for you. Your doctor may change to a preferred drug or if your doctor wants you to stay on the same drug, he/she will need to send more information to Sunshine Health.

If you have questions, please call Sunshine Health Member Services at 1-866-796-0530 (TDD/TTY 1-800-955-8770). Our staff is here Monday through Friday from 8 a.m. to 8 p.m. We are closed on state holidays.